Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli

Jessica E. Flower, William J. Gibbons Jr., Alexandra M. Adams, Xin Wang, Caroline N. Broude, J. Andrew Jones, 2023.

In vivo production of psilocybin in E. coli

Adams AM, Kaplan NA, Wei Z, Brinton JD, Monnier CS, Enacopol AL, Ramelot TA, Jones JA. In vivo production of psilocybin in E. coli. Metabolic engineering. 2019 Dec 1;56:111-9.

In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli

Lucas M. Friedberg, Abhishek K. Sen, Quynh Nguyen, Gabriel P. Tonucci, Elle B. Hellwarth, William J. Gibbons Jr., J. Andrew Jones, 2023.

Use of bacterial co-cultures for the efficient production of chemicals

Jones, J.A. and Wang, X., 2018. Use of bacterial co-cultures for the efficient production of chemicals. Current opinion in biotechnology, 53, pp.33-38.

Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats

Alexandra M. Adams, Nicholas A. Anas, Abhishek K. Sen, Jordan D. Hinegardner-Hendricks, Philip J. O’Dell, William J. Gibbons Jr., Jessica E. Flower, Matthew S. McMurray, J. Andrew Jones, June 2022.

Harnessing synthetic biology to develop novel psychedelic therapies

J. Andrew Jones and Michael G. Spigarelli, 2022.

Homebrewed Psilocybin: Can New Routes for Pharmaceutical Psilocybin Production Enable Recreational Use?

William J. Gibbons Jr., Madeline G. McKinney, Philip J. O’Dell, Brooke A. Bollinger & J. Andrew Jones, 2021.